Which of the COVID-19 patients would benefit from anticoagulant treatment?
Prophylactic low molecular weight heparin, or heparin, has been recommended by the WHO in severe to critically ill COVID-19 patients.125 However, the International Society on Thrombosis and Haemostasis recommended that all hospitalized COVID-19 patients, not just those in ICU, should receive prophylactic low molecular weight heparin in the absence of contraindications.158